The purpose of this study is to evaluate the usefulness of fentanyl matrix by assessing
patients' satisfaction when administrating fentanyl matrix, a background pain treatment, and
a breakthrough pain treatment to lung cancer patients who complain of pain. Fentanyl matrix
is designed to deliver medication at a nearly constant amount per unit time into the body
through the skin for 3 days (72 hours).